How long after cannabis cessation does it take for symptoms of Cannabinoid Hyperemesis Syndrome (CHS) to resolve?

Comment by InpharmD Researcher

The period of long term recovery from cannabinoid hyperemesis syndrome (CHS) is highly variable. The duration to complete relief of symptoms may span days to months, while achieving complete long term recovery from CHS itself may take up to 4 years based on accumulation of THC in adipose tissue and pharmacokinetics.

Background

Cannabis hyperemesis syndrome is characterized by cyclic episodes of nausea, vomiting, and abdominal pain in the setting of chronic cannabis use, driven by dysregulation of the endocannabinoid system and gut–brain axis. Clinically, it progresses through three phases: a prodromal phase lasting months with mild morning nausea, a hyperemesis phase lasting several days marked by severe, frequent vomiting (up to multiple episodes per hour) and autonomic symptoms, and a recovery phase in which symptoms resolve after cessation of cannabis. Acute treatments such as benzodiazepines, haloperidol, droperidol, and topical capsaicin can provide relatively rapid symptomatic relief—often within hours; for example, capsaicin has demonstrated meaningful nausea reduction within 60 minutes, and benzodiazepines or antipsychotics can improve symptoms during emergency care. However, standard antiemetics alone are often insufficient. Temporary relief may also occur with hot showers. Definitive and sustained resolution of symptoms requires complete cessation of cannabis, after which patients typically enter the recovery phase with symptom relief lasting days to months, though recurrence is common if cannabis use resumes. Long-term recovery from cannabis use disorder itself may take 3 months to 4 years, reflecting THC’s accumulation in adipose tissue and prolonged pharmacokinetics. [1]

The hyperemetic phase, characterized by severe nausea and vomiting, typically lasts 24 to 48 hours and resolves with supportive care; however, complete symptom resolution occurs during the subsequent recovery phase, which may persist for days, weeks, or months and is associated with a return to normal eating patterns and weight regain. Case series summarized in the review report that remission of CHS symptoms occurs following sustained cannabis cessation, with documented abstinence periods ranging from approximately 1 month to as long as 9 to 48 months in some patients, although the exact time to symptom resolution is not uniformly specified across studies. Collectively, available data indicate that while acute symptoms may abate within 48 hours, full clinical resolution after cannabis cessation varies and may extend from days to months, depending on the duration of abstinence and follow-up reported. [2]

A recent 2025 case report and literature review described CHS in a 22-year-old female with chronic daily cannabis use who experienced recurrent nausea, vomiting, and abdominal pain over a two-year period despite multiple inconclusive diagnostic evaluations. Diagnosis was established using the Rome IV criteria, which require symptom resolution following at least three months of cannabis cessation. Although the patient initially improved after abstinence, symptom recurrence occurred with resumed cannabis use, highlighting the importance of sustained cessation and patient counseling. However, symptoms of CHS may persist for weeks to months after cessation, making patient education and counseling critical components of management. Therapeutic trials of common antiemetics, including dimenhydrinate and ondansetron, were ineffective, with complete cannabis cessation for at least three months identified as the most effective intervention. [3]

Reiterating the above, a 2018 review also notes various timeframes to symptom resolution after cannabis cessation have been reported, ranging from hours to several weeks. Most cases describe resolution within 1–5 days, though some report up to 2–3 weeks or longer. In several reports, resolution occurs in the context of cannabis cessation, although discontinuation timing is not consistently specified. See Table 1 for a summary of case reports and resolution timelines. [4]

References: [1] Loganathan P, Gajendran M, Goyal H. A Comprehensive Review and Update on Cannabis Hyperemesis Syndrome. Pharmaceuticals (Basel). 2024;17(11):1549. Published 2024 Nov 18. doi:10.3390/ph17111549
[2] Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev. 2011;4(4):241-249. doi:10.2174/1874473711104040241
[3] Cholette-Tétrault S, Grad R. Proper counseling for diagnosis and management of cannabinoid hyperemesis syndrome: a case report. Fam Pract. 2025;42(2):cmae067. doi:10.1093/fampra/cmae067
[4] Pergolizzi JV Jr, LeQuang JA, Bisney JF. Cannabinoid Hyperemesis. Med Cannabis Cannabinoids. 2018;1(2):73-95. Published 2018 Nov 15. doi:10.1159/000494992
Literature Review

A search of the published medical literature revealed 1 study investigating the researchable question:

How long after cannabis cessation does it take for symptoms of Cannabinoid Hyperemesis Syndrome (CHS) to resolve?

Level of evidence

C - Multiple studies with limitations or conflicting results  Read more→



Please see Table 1 for your response.


 

Case reports from a systematic literature search for "cannabinoid hyperemesis" and "cannabis hyperemesis" in May 2018

First author, year [Ref.] Age in years, sex, relevant history Prior reports Hot showers Prior marijuana use Diagnosis/treatment Resolution/follow-up
Alaniz, 2016 [121] 28, F (3 trimester pregnant) Persistent nausea and vomiting leading to loss of consciousness Yes 12 y heavy use Hyperemesis gravidarum at first, then CHS, patient cut back on marijuana use to 1/d Pt lost to follow-up
Bagdur, 2012 [105] 27, M Multiple episodes Yes but eventually they provided little to no relief 6 y CHS, marijuana cessation Symptoms resolved in 48 h after stopping marijuana
Baron, 2011 [138] 28, M 12 y Yes 14 y Prerenal failure secondary to CHS but pt would not agree to d/c marijuana Pt returned to ED with same symptoms and secondary renal dysfunction
Beech, 2015 [132] 42, F Head trauma complications Yes 8 y CHS, marijuana cessation  
Bonnet, 2016 [117] 26, F 2–3 episodes/wk past 5 y Yes 11 y Misdiagnosed, pt read about CHS and reported to physician who confirmed diagnosis Symptoms resolved in 3 wk of cessation, follow-up at 12 mo found she had not resumed marijuana use and had no further symptoms
Braver, 2015 [134] 34, M, veteran with PTSD Persistent vomiting Yes Heavy use, duration not quantified CHS, advised to stop marijuana Patient continued marijuana and returned to ED
Braver, 2015 [134] 44, M Abdominal pain with recurrent vomiting 5 y Yes 30 y CHS Symptoms resolved in 9 h
Brewerton, 2016 [133] 22, F Mental health disorders, binge/purge anorexia, intractable vomiting Yes 7 y CHS, patient became angered and asked to be discharged Unknown
Camilleri, 2018 [54] 51, F Nausea, vomiting, abdominal pain, prior cholecystectomy and hysterectomy No Yes, duration not quantified Common bile duct stone (1 cm) removed which did not improve symptoms; delayed gastric emptying; CHS Pt counseled to stop cannabis, dietary restrictions, antiemetic therapy, referral to mental health provider
Cha, 2014 [136] 44, M Recurrent, every morning, duration NR Yes, suffered burns from hot water >20 y CHS Follow-up at 9 y found pt stopped marijuana use, no return of symptoms
Chang, 2009 [101] 25, F, bipolar disorder, obesity 5 y of intermittent episodes Yes ~7 y CHS 2 h
Cox, 2012 [10] 28, M 2 wk Yes 1.5 g/day CHS; IV lorazepam 1 mg relieved symptoms at once Pt counseled to stop marijuana; at 6 mo follow-up he had done so, no recurrent symptoms
Desjardins, 2015 [135] 17, M 5 ED visits in last year Yes Yes NR CHS About 5 d
Enuh, 2013 [94] 47, M, diabetes Yes Yes 39 y of daily use CHS 3 d
Figueroa-Rivera, 2015 [7] 29, M, anxiety disorder, MDD, SUD Multiple ED visits in past year Yes 16 y, daily use IV lorazepam provided relief; CHS diagnosed 3 d
Fleig, 2011 [6] 28, M, recently unemployed Several days of vomiting preceded this ED visit Yes 10 y regular marijuana use (also cocaine, other drugs); with unemployment marijuana use increased to hourly CHS, referral for detox Symptoms resolved quickly with marijuana cessation but patient was unsure if he wanted to forego use of marijuana
Graham, 2017 [97] 16, F 1 wk of vomiting preceded ED visit NR Regular use of marijuana which increased to manage her nausea and vomiting CHS, treated with topical capsaicin Symptoms resolved quickly with capsaicin; patient was educated about CHS
Graham, 2017 [97] 20, M, asthmatic NR, presented with acute marijuana intoxication Yes Yes Antiemetic therapy prescribed, pt returned following week with same symptoms; CHS was diagnosed, treated with topical capsaicin Symptomatic relief occurred within 30 min of using capsaicin; patient was educated about CHS
Gregoire, 2016 [126] 27, M, bipolar disorder taking Rx lithium 4 wk history nausea, 3 wk vomiting, pt d/c lithium thinking it was causing symptoms Yes 14 y, escalating use CHS confirmed when d/c of marijuana resolved symptoms 25 d of inpatient care required to stabilize psychiatric drug regimen
Habboushe, 2014 [137] 25, M Intractable vomiting (>20/d) for 1 d Yes 8 y Creatinine 3.21 mg/dL, blood urea nitrogen 24 mg/dL, anion gap 34, diagnosed with acute renal failure secondary to dehydration caused by CHS Pt treated for renal failure and discharged after short hospital stay
Heard, 2017 [170] 32, M 12 h intractable vomiting, similar episodes over past 2 mo Yes 10 y CHS, IV haloperidol 5 mg, IV diphenhydramine hydrochloride 25 mg ~1 h
Heise, 2015 [139] 17, M 3 wk, multiple episodes Not reported Regular use, marijuana provided by his mother to manage symptoms Diagnosed with CVS at first presentation but antiemetics not effective; next visit, CHS diagnosed 48 h
Hermes-Laufer, 2016 [140] 26, M, Gilbert's syndrome and myringoplasty 5 y Yes Regular use, duration not quantified Initially diagnosed with gall stones; laparoscopic cholecystectomy and some initial improvement; antiemetics ineffective. Repeated visits, CHS diagnosed NR
Hickey, 2013 [111] 34, M 10 y of episodes about every 2–3 mo Yes >20 y, daily use with short periods of abstinence CHS; IV haloperidol 5 mg, discharged in 8 h 1 h
Iacopetti, 2014 [19] 33, M, PTSD, GERD 2 y (5 hospitalizations) Yes Daily use >2 y, intermittent use prior to that CVS diagnosed initially, revised to CHS on later ED visit Symptoms resolved, pt resistant to d/c marijuana
Inayat, 2017 [114] 27, M 2 y Yes 10 y Pt underwent multiple tests, CHS, lorazepam ineffective, IV haloperidol effective 2 d in hospital provided no relief, symptoms resolved with IV haloperidol
Ishaq, 2014 [141] 42, M 20 y (8 hospitalizations) Yes 28 y Numerous tests before CHS diagnosis Symptoms resolved in hospital; pt d/c marijuana and at 3 mo was symptom-free
Jones, 2016 [113] 18, F 1 y NR Regular use, escalating, not quantified CHS, pt resistant; outpatient treatment with 5 mg haloperidol daily Haloperidol well tolerated, pt d/c marijuana at 3 wk, lost to follow-up
Kast, 2018 [142] 21, M Yes, prior hospitalizations Yes 4 y, including "dabbing" pure THC on marijuana cigarettes Antiemetics ineffective, CHS diagnosed; IV haloperidol 2 mg every 8 h as needed 2 d
Kraemer, 2013 [143] 42, M NR Yes Long term, not quantified Skin rash from hot showers; CHS Yes but duration of time NR
Mahmad, 2015 [144] 32, M 5 days Yes 19 y CHS 1 d
Manoharan, 2018 [145] 16, F 2 d Yes NR CHS Gradual resolution
Manning Meurer, 2018 [180] 21, F, primigravida Multiple NR NR HG initially diagnosed, positive drug tests revised dx to CHS at 30 wk gestation; pt hospitalized for CHS symptoms 9 d postpartum NR
Miller, 2010 [146] 17, M, ADHD, asthma, depression 1 y Yes 3 y CVS first dx, counseled to quit marijuana; dx revised to CHS when marijuana cessation resolved symptoms NR
Miller, 2010 [146] 18, F 2 y (10 ED visits and 3 hospitalizations in 18 mo) Yes 2 y CHS NR
Mohammed, 2013 [147] 26, M 6 mo Yes 2 y CHS 48 h
Moon, 2018 [22] 47, M 8 y NR 10 y CHS but continued use of marijuana; next ED visit treated with capsaicin 0.075% every 4 h as needed 4 h
Morris, 2014 [148] 20, F, migraineur 9 mo Yes 4 y CHS NR
Muschart, 2015 [99] 28, M 4 y, about 6 episodes/y Cold showers Several y of daily use, not quantified "Non-classical" CHS, pt resistant to d/c cannabis; pt also had bradycardia NR
Nicolson, 2012 [149] 22, F, low back pain relieved with marijuana 5 y, multiple hospitalizations and up to 2 ED visits/mo Yes 5 y CHS 4 d, but pt continued marijuana use and had further CHS hospitalizations
Nicolson, 2012 [149] 24, M 2 y, episodes every 2–3 mo, multiple hospitalizations Yes 10 y CHS 1 wk; pt refused further care, lost to follow-up
Nicolson, 2012 [149] 20, F, depression, anxiety 1.5 y, 4 hospitalizations Yes 3.5 y CHS 2 d
Nogi, 2014 [150] 32, F, migraineur "Several years" Yes >10 y CHS Nausea persisted
Nourbakhsh, 2018 [171] 27, F Pt found unresponsive, emergency services called, heart rate 40 beats per minute, hypoglycemic, 8 y history of vomiting; pt had been in ER 2 d prior for intractable vomiting NR Long history, not quantified Pt developed VF and died 2 h after being brought to ED; sinus rhythm deteriorated to ventricular fibrillation; autopsy stated she died of complications of CHS Fatality
Nourbakhsh, 2018 [171] 27, M Pt had been vomiting excessively for 5–6 d before his death, history of cyclic vomiting; he was found deceased NR Long history, pt was in drug rehab center at the time of death Pt was dehydrated with dry mucus membranes; autopsy results were death due to complications of chronic cannabis use Fatality
Parekh, 2016 [151] 38, M, GERD 20 y, 3–4 episodes/mo Yes 20 y CHS 1 d
Phillips, 2017 [116] 34, M 3 y, episodes about 2× per wk, multiple ED visits Yes 9 y CHS NR
Price, 2011 [152] 30, M 3 d Yes "Years," not quantified CHS 4 d
Ramadurai, 2016 [153] 21, M 1 y (5 hospitalizations in y) Yes 2 y CHS NR
Roca-Pallin, 2013 [154] 36, F, 2° burns on 20% of body, anxiety 5 y, multiple hospital visits Yes 5 y CHS Several days
Roche, 2005 [155] 21, M 2 y (7 hospitalizations) Yes Yes, duration not quantified CHS, diagnosed when his girlfriend suggested CHS (and he fit profile) NR
Sannarangappa, 2009 [156] 34, M, abdominal rash from hot water bottle 10 y Yes 15 y CHS after pt reported 2 y abstinence from marijuana alleviated symptoms 5 d
Sawni, 2016 [125] 15, F 7 mo, 4 hospitalizations Yes >1 y, escalating use CHS NR
Sawni, 2016 [125] 16, F 4 mo, 4 hospitalizations Yes Yes, not quantified and included secondhand marijuana smoke from family CHS NR
Schmid, 2011 [157] 26, F, 10 wk pregnant 3.5 y, prior hospitalizations Yes 13 y CHS Pt d/c marijuana about 10 d prior to hospitalization when she learned she was pregnant 2 wk
Singh, 2008 [158] 46, M 3 y, multiple prior ED visits Yes >30 y First CVS, revised to CHS with cannabis history NR
Sontineni, 2009 [159] 22, M 2 mo, 2 prior ED visits Yes 6 y CHS after pt disclosed cannabis use NR
Torka, 2012 [160] 20, M NR Yes 2–3 y Pancreatitis initial dx, use of hot showers led to CHS dx NR
Torka, 2012 [160] 29, M 3 mo Yes 3 mo ST elevations, pt history led to dx of CHS NR
Trappey, 2017 [172] 24, M Pt had 25 ED visits and 6 hospitalizations in past 4 y for intractable vomiting; he vomited for 2 d and was hospitalized, returned home and presented at ED 3 d later with same symptoms Yes, but when hot water was not available he jogged as exercise reduced symptoms resulting in exercise-induced rhabdomyolysis requiring IV hydration Described as "extensive," not quantified CHS had been diagnosed earlier but pt did not discontinue marijuana, in fact, he continued its use thinking it could help symptoms; pt continues to use marijuana and has been rehospitalized 24 h
Valdivielso-Cortazar, 2018 [173] 30, F Cyclic vomiting, abdominal pain, presented during an episode of stomach pain, nausea, and vomiting Yes 14 y CHS was diagnosed and patient was counseled to abstain from marijuana NR
Wallace, 2007 [161] 30, M 5 y, 14 ED visits, 3 hospitalizations Yes 16 y Initial diagnosis was stress-related vomiting, revised to PV, then CHS when symptoms described in 2004 NR
Warner, 2014 [162] 28, M 9 mo, repeated ED visits Yes 13 y Pt initially denied use of marijuana and later minimized it; diagnosis of CHS when marijuana use and hot showers were disclosed NR
Wild, 2012 [163] 21, F 4 wk NR 7 y CHS when gastroenteritis was ruled out (no diarrhea) NR
Williamson, 2014 [164] 39, M 6 y, at least 2× per mo Yes 20 y CHS 48 h
Williamson, 2014 [164] 19, M 2 wk NR 2 y CHS 48 h
Woods, 2016 [165] 37, M 14 y, 18 admissions in past 5 y Yes "Long term" not quantified CHS 4 d

Synthetic marijuana

Argamany, 2016 [166]

27, M 1 wk NR Recent use of synthetic marijuana Acute renal failure attributed to rhabdomyolysis secondary to CHS Emergent hemodialysis not needed and kidney function returned to normal in about 1 wk
Bick, 2014 [167] 29, M Recurrent episodes, sought help at PC, then ED Yes Patient denied use of marijuana and tested negative for THC but used K2 and Kryptonite (synthetic marijuana) regularly CHS 6 mo
Hopkins, 2013 [168] 30, M 2 y Yes 17 y, then drug testing required for parole led him to daily use of undetectable synthetics, K2, Spice, Scooby Snacks CHS Symptoms resolved in 2 wk; all marijuana d/c and pt symptom-free at 3 mo
Ukaigwe, 2014 [169] 38, M NR but past episodes had occurred Yes NR but described as "long term": use of marijuana and synthetics CHS with prerenal acute kidney injury 2 wk (both CHS and renal symptoms)

Abbreviations: ADHD, attention deficit hyperactivity disorder; CHS, cannabinoid hyperemesis syndrome; d, day; d/c, discontinued, discontinuation; ED, emergency department; F, female; GERD, gastroesophageal reflux disorder; h, hour; HG, hyperemesis gravidarum; M, male; MDD, major depressive disorder; NR, not reported; PC, primary care; pt, patient; PTSD, posttraumatic stress disorder; Rx, prescribed/prescription; SUD, substance use disorder; wk, week; y, year(s); yo, years old. Studies are presented in alphabetical order by last name of first author of the report, and studies involving specifically synthetic cannabinoids appear at the end. As these case studies were conducted independently and did not always report the same data (for instance, some had no data on treatment or resolution or prior marijuana use), it was not possible to synthesize this information in any scientifically sound or clinically meaningful way. It is fair to glean from the chart some basic information, namely that no patient from a case study is >51 years old, the majority are men with a long history of marijuana use, many had previous encounters with the healthcare system before CHS was diagnosed, most found relief in hot showers, and, when reported, symptoms typically resolved in a short time when marijuana was discontinued.

References correspond to the cited literature sources described in the text.

 

References:
[1] [1] Adapted from: Pergolizzi JV Jr, LeQuang JA, Bisney JF. Cannabinoid Hyperemesis. Med Cannabis Cannabinoids. 2018;1(2):73-95. Published 2018 Nov 15. doi:10.1159/000494992